Osimertinib (Tagrisso): Advanced Treatment for EGFR-Positive Lung Cancer Osimertinib, marketed under the brand name Tagrisso, is a cutting-edge oral medication used primarily for the treatment of non-small cell lung cancer…
Lorlatinib: A Targeted Therapy for ALK-Positive Lung Cancer Lorlatinib is a next-generation tyrosine kinase inhibitor (TKI) designed to treat ALK-positive non-small cell lung cancer (NSCLC). Approved by the FDA and…
Acalabrutinib: Uses, Benefits, Dosage, Side Effects & More Acalabrutinib is a next-generation Bruton tyrosine kinase (BTK) inhibitor used primarily in the treatment of certain types of blood cancers. Marketed under…
Enasidenib: Uses, Benefits, Dosage & Side Effects Enasidenib (brand name: Idhifa) is an FDA-approved prescription medication used to treat relapsed or refractory acute myeloid leukemia (AML) in adults with an…
Reviews
There are no reviews yet.